IGF1 and obesity due to melanocortin 4 receptor deficiency: However, there is evidence that circulating insulin-like growth factor-I (IGF-I), which is influenced by environmental factors, is related to higher prostate cancer risk (Travis et al, 2016), and the latest World Cancer Research Fund meta-analysis of prospective studies concluded that it is probable that obesity is associated with a higher incidence of aggressive prostate cancer.